Patents

EU Patent No. 0971741

Use of avian antibodies against an antigen/pathogen causing respiratory tract infections for the production of a pharmaceutical solution for treatment and/or prevention of infections in the nasal cavity, paranasal sinuses, the lymphatic ring in the oropharynx, larynx, trachea, bronchi, bronchioli and/or alveoli, wherein the pharmaceutical solution is administered by local application at the oral cavity and/or pharynx.

Patents with identical claims: Mexico Patent No. 225169 and Poland Patent No. PAT-189128

Australia Patent No. 733107

Use of avian antibodies for the production of a drug for treatment and/or prevention of infections affecting the bronchi, lungs, trachea and/or the lymphatic ring in oropharynx, wherein the drug is adapted for local application at the oral cavity and pharynx.

Patents with identical claims: Indonesia Patent No. ID0013761

US Patent No. 6537550

The present invention relates to use of avian antibodies and/or antigen binding fragments thereof, for the production of a drug for treatment and/or prevention of respiratory tract infection. The drug is administered through local application at the oral cavity and/or pharynx.